1.
Alam J, Panezai SA, Shaikh U, Kumari L, Muhammad Ilyas, kakar SU. Impact of Infections in Patients with Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax during Induction Chemotherapy. IJBR [Internet]. 2025 Jan. 10 [cited 2026 Apr. 9];3(1):190-6. Available from: https://induspublishers.com/index.php/IJBR/article/view/469